Australasian Leukaemia & Lymphoma Group 35 Elizabeth Street, Richmond, Victoria 3121

Welcome to the Australasian Leukaemia & Lymphoma Group (ALLG), located at 35 Elizabeth Street, Richmond, Australia. As a prominent establishment and point of interest, the ALLG brings together over 1,000 blood cancer specialists who share a common goal of finding better ways to treat blood cancers through clinical trial conduct.

As Australia and New Zealand's only not-for-profit blood cancer clinical trial research group, the ALLG is dedicated to improving the treatment, lives, and survival rates of patients with blood cancers. Our mission, "Better treatments... Better lives," drives us to collaborate with local and international blood cancer specialists, ensuring our impact is profound.

Thanks to our strong partnerships and collaborations, the ALLG had a successful financial year. We extend our gratitude to our members and patients who have played a crucial role in this achievement. We eagerly look forward to conducting more trials that create better treatments and better lives.

Our annual Research Report for the calendar year 2022 provides comprehensive summaries and detailed information on the current ALLG clinical trial program. We express our appreciation to the Scientific Advisory Committee, Scientific Working Party Chairs, and committee members for their dedication in advancing ALLG clinical trials, ultimately providing patients with improved treatments.

By becoming a member of the ALLG, you can make a difference in the lives of those affected by blood cancer. Your donation helps increase the chances of a cure and enhances the quality of life for patients and their loved ones. Additionally, membership grants you access to cutting-edge, potentially life-saving treatments before they become widely available to the public. Clinical trials have significantly extended the lifespan and improved the quality of life for many cancer patients.

The ALLG's Laboratory Science research plays a vital role in determining which patients benefit from targeted therapy for their blood cancer. You can explore this and more in our latest quarterly publication.

We are proud to introduce the HeSANDA platform, a comprehensive catalogue of research metadata from clinical trials conducted across Australia. This platform enables researchers to access and share data from health studies, leading to advancements in medical research.

Congratulations to Dr. Ruth Spearing, an ALLG Life Member, for being honored in the 2023 King's Birthday New Zealand and Coronation Honours. She has been made a Companion of the New Zealand Order, recognizing her significant contributions to the field.

We are thrilled to announce that two ALLG clinical trials, ALL08 BLAM and NHL29 IRIC, have been accepted as abstracts with poster presentations at prestigious European scientific conferences.

Since 1973, the ALLG's purpose has remained steadfast: "Better treatments... Better lives." Our commitment to improving the treatment, lives, and survival rates of patients with blood cancer remains unwavering.

The Australasian Leukaemia and Lymphoma Group is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity, ensuring that your support goes directly towards our mission.

Visit us at Ground Floor, 35 Elizabeth Street, Richmond VIC 3121, and join us in acknowledging the Traditional Owners of Country throughout Australia. We recognize their continuing connection to lands, waters, and communities and pay our respects to Aboriginal and Torres Strait cultures, as well as Elders past and present.